Minerva Neurosciences, Inc.

NERV ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
3 Aug 20, 2026
3 Aug 20, 2026
SCHEDULE 13G/A Aug 14, 2026
SCHEDULE 13G/A Aug 13, 2026
8-K Aug 12, 2026 8-K
10-Q Aug 7, 2026 10-Q
8-K Aug 7, 2026 8-K
4 Aug 3, 2026
SCHEDULE 13G/A Jul 8, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
4 Jun 5, 2026
8-K Jun 4, 2026 8-K
8-K May 27, 2026 8-K
424B5 May 27, 2026 424B5
SCHEDULE 13G May 15, 2026
SCHEDULE 13G/A May 15, 2026
10-Q May 5, 2026 10-Q
8-K May 5, 2026 8-K
ARS Apr 23, 2026 ARS
DEFA14A Apr 23, 2026 DEFA14A
← Newer Page 1 of 26 · 643 filings Older →